CTR9 anticorps
-
- Antigène Voir toutes CTR9 Anticorps
- CTR9 (RNA Polymerase-Associated Protein CTR9 Homolog (CTR9))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CTR9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- Ctr9, Paf1/RNA polymerase II complex component, homolog(S. cerevisiae)
- Isotype
- IgG
- Top Product
- Discover our top product CTR9 Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- CTR9 (RNA Polymerase-Associated Protein CTR9 Homolog (CTR9))
- Autre désignation
- CTR9 (CTR9 Produits)
- Synonymes
- anticorps SH2BP1, anticorps TSBP, anticorps p150, anticorps p150TSP, anticorps AA409336, anticorps Sh2bp1, anticorps Tsbp, anticorps Tsp, anticorps mKIAA0155, anticorps sh2bp1, anticorps p150tsp, anticorps tsbp, anticorps fc54a06, anticorps wu:fc54a06, anticorps CTR9 homolog, Paf1/RNA polymerase II complex component, anticorps CTR9 homolog, Paf1/RNA polymerase II complex component S homeolog, anticorps Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae), anticorps RNA polymerase-associated protein CTR9 homolog, anticorps CTR9, anticorps Ctr9, anticorps ctr9.S, anticorps ctr9, anticorps LOC100161197, anticorps LOC100163982, anticorps LOC100168634, anticorps LOC100478349, anticorps LOC100543206, anticorps LOC100645071
- Sujet
- Synonyms:KIAA0155, SH2BP1 Background:Component of the PAF1 complex(PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'-and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both indepentently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1, it promotes leukemogenesis through association with KMT2A/MLL1-rearranged oncoproteins, such as KMT2A/MLL1-MLLT3/AF9 and KMT2A/MLL1-MLLT1/ENL. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4'(H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B(H2BK120ub1), UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. In case of infection by influenza A strain H3N2, PAF1C associates with viral NS1 protein, thereby regulating gene transcription. Required for mono-and trimethylation on histone H3 'Lys-4'(H3K4me3) and dimethylation on histone H3 'Lys-79'(H3K4me3). Required for Hox gene transcription. Required for the trimethylation of histone H3 'Lys-4'(H3K4me3) on genes involved in stem cell pluripotency, this function is synergistic with CXXC1 indicative for an involvement of the SET1 complex. Involved in transcriptional regulation of IL6-responsive genes and in JAK-STAT pathway, may regulate DNA-association of STAT3(By similarity).
- Poids moléculaire
- 130-150kd
- ID gène
- 9646
- UniProt
- Q6PD62
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Stem Cell Maintenance
-